Risk of death among persons with Alzheimer's disease: A national register-based nested case-control study

Journal of Alzheimer's Disease

Volumn 33, Issue 1, 2013, Pages 157-164

  Lönnroos, Eija ^a   Kyyrönen, Pentti ^b   Bell, J Simon ^a,c   Van Der Cammen, Tischa J M ^d   Hartikainen, Sirpa ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; case control study; mortality; register based

Indexed keywords

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; FINLAND; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; REGISTER;

EID: 84872451670     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120808     Document Type: Article

References (42)

1. Alzheimer's Association, Thies W, Bleiler L (2011) Alzheimer's disease facts and figures. Alzheimers Dement 7, 208-244.
2. Rocca WA, Petersen RC, Knopman DS, Hebert LE, Evans DA, Hall KS, Gao S, Unverzagt FW, Langa KM, Larson EB, White LR (2011) Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement 7, 80-93.
3. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3, 186-191. (Pubitemid 46825511)
4. Wimo A, Jonsson L, Winblad B (2006) An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord 21, 175-181. (Pubitemid 43201328)
5. Aevarsson O, SvanborgA, Skoog I (1998) Seven-year survival rate after age 85 years: Relation to Alzheimer disease and vascular dementia. Arch Neurol 55, 1226-1232.
6. Ostbye T, Hill G, Steenhuis R (1999) Mortality in elderly Canadians with and without dementia: A 5-year follow-up. Neurology 53, 521-526. (Pubitemid 29382045)
7. Ag?uero-Torres H, Fratiglioni L, Guo Z, Viitanen M,Winblad B (1999) Mortality from dementia in advanced age: A 5-year follow-up study of incident dementia cases. J Clin Epidemiol 52, 737-743. (Pubitemid 29361449)
8. Tschanz JT, Corcoran C, Skoog I, Khachaturian AS, Herrick J, Hayden KM, Welsh-Bohmer KA, Calvert T, Norton MC, Zandi P, Breitner JC, Cache County Study Group (2004) Dementia: The leading predictor of death in a defined elderly population: The Cache County Study. Neurology 62, 1156-1162. (Pubitemid 38456511)
9. Nitrini R, Caramelli P, Herrera E Jr, de Castro I, Bahia VS, Anghinah R, Caixeta LF, Radanovic M, Charchat-Fichman H, Porto CS, Teresa Carthery M, HartmannAP, Huang N, Smid J, Lima EP, Takahashi DY, Takada LT (2005) Mortality from dementia in a community-dwelling Brazilian population. Int J Geriatr Psychiatry 20, 247-253. (Pubitemid 40426025)
10. Brookmeyer R, Corrada MM, Curriero FC, Kawas C (2002) Survival following a diagnosis of Alzheimer disease. Arch Neurol 59, 1764-1767. (Pubitemid 35340487)
11. Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W (2005) Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci 229-230 43-49. (Pubitemid 40341563)
12. Koedam EL, Pijnenburg YA, Deeg DJ, Baak MM, van der Vlies AE, Scheltens P, van der Flier WM (2008) Early-onset dementia is associated with higher mortality. Dement Geriatr Cogn Disord 26, 147-152.
13. Bowen JD, Malter AD, Sheppard L, KukullWA,McCormick WC, Teri L, Larson EB (1996) Predictors of mortality in patients diagnosed with probable Alzheimer's disease. Neurology 47, 433-439. (Pubitemid 26324039)
14. Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA (2004) Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 140, 501-509.
15. Steenland K, MacNeil J, Seals R, Levey A (2010) Factors affecting survival of patients with neurodegenerative disease. Neuroepidemiology 35, 28-35.
16. Gambassi G, Lapane KL, Landi F, Sgadari A, Mor V, Bernabie R (1999) Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group. Neurology 53, 508-516.
17. Sinforiani E, Citterio A, Zucchella C, Bono G, Corbetta S, Merlo P, Mauri M (2010) Impact of gender differences on the outcome of Alzheimer's disease. Dement Geriatr Cogn Disord 30, 147-154.
18. Hui JS, Wilson RS, Bennett DA, Bienias JL, Gilley DW, Evans DA (2003) Rate of cognitive decline and mortality in Alzheimer's disease. Neurology 61, 1356-1361. (Pubitemid 37463370)
19. Carcaillon L, Ṕeres K, Ṕeŕe JJ, Helmer C, Orgogozo JM, Dartigues JF (2007) Fast cognitive decline at the time of dementia diagnosis: A major prognostic factor for survival in the community. Dement Geriatr Cogn Disord 23, 439-445. (Pubitemid 46897182)
20. Statistics Finland (2011) Causes of death in 2009, http:www.stat.fi/til/ ksyyt/2009/01/ksyyt 2009 01 2011-02-22 kat 002 en.html, Accessed February 20, 2012.
21. Furu K,Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT (2010) The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106, 86-94.
22. Population Register Centre of Finland. The Finnish Population Information System, http://www.vaestorekisterikeskus. fi/default.aspx?id=39, Accessed February 20, 2012.
23. Statistics Finland (2011) Quality description, deaths, http://www.tilastokeskus.fi/til/kuol/2010/kuol 2010 2011-04-15 laa 001 en.html, Accessed February 20, 2012.
24. Kajantie M, Manderbacka K, McCallum A, Notkola IL, Arffman M, Forssas E, Karvonen S, Kortteinen M, Leyland A, Keskim?aki I (2006) How to carry out registerbased health services research in Finland. In STAKES Discussion papers 1/2006 [online], http://www.stakes.fi/ verkkojulkaisut/papers/DP1-2006.pdf, Accessed February 20, 2012.
25. Bell JS, Laitinen ML, Lavikainen P, L?onnroos E, Uosukainen H, Hartikainen S (2011) Use of strong opioids among community-dwelling persons with and without Alzheimer's disease in Finland. Pain 152, 543-547.
26. Bell JS, L?onnroos E, Koivisto AM, Lavikainen P, Laitinen ML, Soininen H, Hartikainen S (2011) Use of antiepileptic drugs among community-dwelling persons with Alzheimer's disease in Finland. J Alzheimers Dis 26, 231-237.
27. Laitinen ML, Bell JS, Lavikainen P, L?onnroos E, Sulkava R, Hartikainen S (2011) Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland. Int Psychogeriatr 23, 1623-1631.
28. Working group appointed by the Finnish Medical Society Duodecim, Societas Gerontologica Fennica, the Finnish Neurological Society, Finnish Psychogeriatric Association and the Finnish Association for General Practice. Memory disorders. Current Care Guideline [serial online], http://www. terveysportti.fi/xmedia/hoi/hoi50044.pdf, Accessed February 20, 2012.
29. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text revision. Washington, D.C.
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944. (Pubitemid 14076461)
31. Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST (2005) Alzheimer disease and mortality: A 15-year epidemiological study. Arch Neurol 62, 779-784. (Pubitemid 40656094)
32. Barclay LL, Zemcov A, Blass JP, McDowell FH (1985) Factors associated with duration of survival in Alzheimer's disease. Biol Psychiatry 20, 86-93. (Pubitemid 16051971)
33. Newens AJ, ForsterDP, KayDW, KirkupW, Bates D,Edwardson J (1993) Clinically diagnosed presenile dementia of the Alzheimer type in the Northern Health Region: Ascertainment, prevalence, incidence and survival. Psychol Med 23, 631-644. (Pubitemid 23268081)
34. Fratiglioni L, Viitanen M, von Strauss E, Tontodonati V, Herlitz A, Winblad B (1997) Very old women at highest risk of dementia and Alzheimer's disease: Incidence data from the Kungsholmen Project, Stockholm. Neurology 48, 132-138. (Pubitemid 27039531)
35. Tilvis RS, Strandberg TE, Juva K (1998) Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Ger Soc 46, 712-715. (Pubitemid 28262346)
36. Gavett BE, Stern RA, Cantu RC, Nowinski CJ, McKee AC (2010) Mild traumatic brain injury: A risk factor for neurodegeneration. Alzheimers Res Ther 2, 18.
37. Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, ColeyN, Cantet C, Gauthier S, Ousset PJ,Vellas B, REAL.FR study group (2011) Long-term progression of Alzheimer's disease in patients under antidementia drugs. Alzheimers Dement 7, 579-592.
38. Herrmann N, Gill SS, Bell CM, Anderson GM, Bronskill SE, Shulman KI, Fischer HD, Sykora K, Shi HS, Rochon PA (2007) A population-based study of cholinesterase inhibitor use for dementia. J Am Geriatr Soc 55, 1517-1523. (Pubitemid 47508507)
39. Suh GH, Ryu SH, Lee DW, Han C, Ju YS, Kee BS, Lee JN, Bae JN, Choi JH, Kim DJ, Lee NJ, Lee JY, Go HJ, Yi JS, Cho SJ, Jeon YW (2011) Cholinesterase inhibitors for Alzheimer disease: Do they provide more than symptomatic benefits? Am J Geriatr Psychiatry 19, 266-273.
40. Virta L, Viramo P (2007) Incidence of cholinergic and memantine treatment in Alzheimer's disease in Finland. J Am Geriatr Soc 55, 1886-1887. (Pubitemid 350043762)
41. Ik?aihmisten palvelujen laatusuositus. Sosiaali- ja terveysministeri ?on julkaisuja 2008:3, http://www.stm.fi/c/ document library/get file?folderId=28707&name=DLFE-3672.pdf&title=Ikaihmisten palvelujen laatusuositus fi.pdf, Accessed June 5, 2012.
42. Neumann PJ, Araki SS, Arcelus A, Longo A, Papadopoulos G, Kosik KS, Kuntz KM, Bhattacharjya A (2001) Measuring Alzheimer's disease progression with transition probabilities: Estimates from CERAD. Neurology 57, 957-964. (Pubitemid 32880186)